Authors
Loading...
Single-center prospective trial examines biomarkers in lung injury for COVID-19 and idiopathic pulmonary fibrosis, indicating their clinical relevance.
Gendron et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: